Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Comparison of NGS for Hepatitis C viral genomes

ABSTRACT: Comparison of next generation sequencing technologies for the comprehensive assessment of full-length hepatitis C viral genomes

PROVIDER: PRJEB11791 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR1810450.fastq.gz	Fastqsanger.gz
	ERR1810450_1.fastq.gz	Fastqsanger.gz
	ERR1810450_2.fastq.gz	Fastqsanger.gz
	ERR1810460_1.fastq.gz	Fastqsanger.gz
	ERR1810460_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 211

Similar Datasets

NGS in Autoimmune Hepatitis

Project description:Next-generation immunosequencing reveals pathological T cell architecture in autoimmune hepatitis

| PRJEB37143 | ENA

Saccharomyces cerevisiae BY4741

Project description:Full-length RNA sequencing using Illumina and Nanopore technologies

| PRJDB8048 | ENA

Three Hepatitis B genomes from ancient samples

Project description:Three hepatitis B genomes were recovered from ancient human bones

| PRJEB24921 | ENA

Hepatitis B virus

Project description:Molecular characterization of full genome hepatitis b virus sequences from an urban hospital cohort in Pretoria, South Africa

| PRJNA737147 | ENA

Anticodon Engineered Transfer RNA (tRNASUAG) Inhibits Hepatitis B Virus Replication by Promoting Degradation of the Core Protein

Project description:Current antiviral drugs targeting hepatitis B virus (HBV) still face challenges in achieving functional cure for chronic hepatitis B. Therefore, it is necessary to explore new therapeutic approaches and combination therapy strategies. Anticodon engineered transfer RNA (ACE-tRNA) has been widely applied in the treatment of genetic diseases caused by nonsense mutations. However, its role in antiviral therapy has not been reported yet. In this study, ACE-tRNAs were designed targeting the highly conserved stop codon (UAG) of HBV core protein (HBc). All designed ACE-tRNAs can read through the stop codon of HBc. Among them, tRNASUAG promoted HBc phosphorylation by introducing a phosphorylatable serine into the C-terminal domain of HBc, thereby reducing HBc levels and inhibiting HBV replication by promoting the degradation of HBc through the ubiquitin-proteasome pathway. In addition, ACE-tRNA and CRISPR/Cas9 technologies can be effectively integrated through a tRNASUAG-gRNA tandem array and achieve the combined inhibition of HBV replication. This is the first study to use ACE-tRNA to promote HBc degradation by introducing an amino acid that can be post-translationally modified and subsequently inhibit HBV replication. In addition, this study presents a promising therapeutic strategy for promoting the clearance of HBV infection by integrating ACE-tRNA and CRISPR/Cas9 technologies.

2025-12-08 | PXD063150 | Pride

Association Between Hepatitis C Infection and Renal Cell Carcinoma

Project description:The purpose of this study is to determine if there is an association between hepatitis C infection and kidney cancer. All patients who are diagnosed with kidney cancer and who will either have a biopsy or surgery will be offered to be tested for hepatitis C. The control group will be colon cancer patients. Both groups would be of recent diagnosis (6 months).

| 2110600 | ecrin-mdr-crc

Comparison of technologies

Project description:Comparison of technologies

| PRJEB26322 | ENA

MURDOCK - Duke Hepatitis C - Predicting Treatment response to Hepatitis C, PEG-IFN/Ribavirin

Project description:Predicting Treatment response to Hepatitis C, PEG-IFN/Ribavirin

2010-01-04 | PRD000181 | Pride

Gene expression profiling of hepatitis B- and hepatitis C-related hepatocellular carcinoma using graphical Gaussian modeling

Project description:Gene expression profiling of hepatocellular carcinoma (HCC) and background liver has been studied extensively; however, the relationship between the gene expression profiles of different lesions has not been assessed. We examined the expression profiles of 34 HCC specimens (17 hepatitis B virus [HBV]-related and 17 hepatitis C virus [HCV]-related) and 71 non-tumor liver specimens (36 chronic hepatitis B [CH-B] and 35 chronic hepatitis C [CH-C]) using an in-house cDNA microarray consisting of liver-predominant genes. Graphical Gaussian modeling (GGM) was applied to elucidate the interactions of gene clusters among the HCC and non-tumor lesions. Gene expression profiling of HCC and non-tumor lesions revealed the predisposing changes of gene expression in HCC. This approach has potential for the early diagnosis and possible prevention of HCC. We examined the expression profiles of 34 HCC specimens (17 hepatitis B virus [HBV]-related and 17 hepatitis C virus [HCV]-related) and 71 non-tumor liver specimens (36 chronic hepatitis B [CH-B] and 35 chronic hepatitis C [CH-C]) using an in-house cDNA microarray consisting of liver-predominant genes. Graphical Gaussian modeling (GGM) was applied to elucidate the interactions of gene clusters among the HCC and non-tumor lesions.

2013-11-14 | E-GEOD-44074 | biostudies-arrayexpress

Hepatitis B virus

Project description:Hepatitis B virus Epigenomics

| PRJNA377217 | ENA